USA
Cours de l'action
63.23 €
Lipiodol
Guerbet has acquired the Ethiodol® NDA from Nycomed US Inc. effective May 7, 2010 and is working with the FDA to resume manufacturing of Ethiodol in the near future to ensure continued availability for the US patients.
Accreditation
Sales Representative
To find your local Medical Center Professional, please enter your zip code: